Pancreatic Cancer Awareness
Pancreatic cancer is the 7th most common cancer amongst both genders in Cyprus, but it has a very high fatality rate, with an estimated 5-year survival rate of only 5-10% after diagnostics.
Pancreatic cancer is the 7th most common cancer amongst both genders in Cyprus, but it has a very high fatality rate, with an estimated 5-year survival rate of only 5-10% after diagnosis. Pancreatic cancer is correlated with older age, as almost 90% of diagnosed patients are over 55 years old. Although rare, pancreatic cancer can still occur in people under the age of 30, mostly due to genetic predisposition.
Latest studies, suggest that obesity increases the risk of pancreatic cancer. Other potential risk factors include physical inactivity, excessive aspirin use, occupational exposure to certain pesticides, as well as dietary factors such as surplus carbohydrate or sugar intake. Furthermore, smoking or having diabetes and certain hereditary conditions have been proved to be risk factors for pancreatic cancer.
Annually in Cyprus
Annually in Cyprus
a Single Symptom
While these stats paint a bleak picture of the disease, pancreatic cancer can be survived with early diagnosis.
“There is a lack of targeted initiatives devoted to pancreatic cancer, and only some countries are using cancer registries to collect data on pancreatic cancer. Through joint action, the European Cancer Patient Coalition is part of a dedicated mission to identify opportunities for improving detection, diagnosis and access to clinical expertise for every European affected by pancreatic cancer.”
Francesco de Lorenzo – ECPC Past-President and Chair of the Scientific Committee
The idea behind this event, a "A day of action, a world of difference", is to unite everyone under the common goal of seeking a new outlook for patients with this disease. By providing education about the disease and increasing awareness of its devastating impact, we hope to change the outlook for patients and families and ensure that there is more dedicated research and funding that can help save lives and change their future.
Find out how to get involved here:
The content is intended for educational purposes only and should not be perceived as medical advice. Hereditary cancer testing, possible next steps and clinical management should always be fully discussed with your healthcare provider.
Compiled using information from:
International Agency for Research on Cancer.pdf